Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 32 results for shockwave

  1. Evidence on the safety of extracorporeal shockwave therapy for calcific tendinopathy in the shoulder shows no major safety concerns in the short term. Evidence on efficacy is inadequate. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page

    IPG742/01 Question Evidence on the safety of extracorporeal shockwave therapy for calcific tendinopathy in the shoulder shows no major...

    Research recommendation
    Published
    12 December 2022

  2. Autologous blood injection for plantar fasciitis (HTG298)

    Evidence-based recommendations on autologous blood injection for plantar fasciitis. This involves supplying the connective tissue with growth factors that promote the healing process.

    HealthTech guidance
    Published
    23 January 2013
    View recommendations

    Sections for HTG298

  3. Autologous blood injection for tendinopathy (HTG299)

    Evidence-based recommendations on autologous blood injection for tendinopathy. This involves supplying the tendon with growth factors that start the healing process.

    HealthTech guidance
    Published
    23 January 2013
    View recommendations

    Sections for HTG299

  4. Cost saving guidance

    management (NG118) Savings result from many areas, including an increase in shockwave lithotrips and a reduction in surgical...

  5. Laparoscopic nephrolithotomy and pyelolithotomy (HTG137)

    Evidence-based recommendations on laparoscopic nephrolithotomy and pyelolithotomy. This involves inserting a tube through small cuts in the abdomen (keyhole surgery) to remove the kidney stones..

    HealthTech guidance
    Published
    28 March 2007
    View recommendations

    Sections for HTG137

  6. Pancreatitis (NG104)

    This guideline covers managing acute and chronic pancreatitis in children, young people and adults. It aims to improve quality of life by ensuring that people have the right treatment and follow-up, and get timely information and support after diagnosis.

    NICE guideline
    Last updated
    16 December 2020
    View recommendations

    Sections for NG104

  7. Renal and ureteric stones (QS195)

    This quality standard covers assessing and managing renal and ureteric stones in children, young people and adults. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    29 July 2020
    View quality statements

    Sections for QS195

  8. Extracorporeal shockwave therapy for Peyronie's disease (IPG29)

    We have moved interventional procedures guidance 29 to become HealthTech guidance 11. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  9. Extracorporeal shockwave therapy for Achilles tendinopathy (IPG571)

    We have moved interventional procedures guidance 571 to become HealthTech guidance 426. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  10. Extracorporeal shockwave therapy for refractory tennis elbow (IPG313)

    We have moved interventional procedures guidance 313 to become HealthTech guidance 201. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  11. Extracorporeal shockwave therapy for refractory plantar fasciitis (IPG311)

    We have moved interventional procedures guidance 311 to become HealthTech guidance 200. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  12. Extracorporeal shockwave therapy for refractory Achilles tendinopathy (IPG312)

    Interventional procedures, IPG312 - Issued: August 2009 --> This guidance has been updated and replaced by NICE interventional procedure guidance 571.

    Withdrawn guidance

  13. Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder (IPG742)

    We have moved interventional procedures guidance 742 to become HealthTech guidance 645. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  14. Extracorporeal shockwave lithotripsy for calcific tendonitis (tendinopathy) of the shoulder (IPG21)

    This guidance has been updated and replaced by NICE interventional procedures guidance 742.

    Withdrawn guidance

  15. Extracorporeal shockwave therapy for refractory greater trochanteric pain syndrome (IPG376)

    We have moved interventional procedures guidance 376 to become HealthTech guidance 248. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance